8 Followers USX:LLY - Eli Lilly and Co Eli Lilly and Company
Sector: Health Care, Industry: Pharmaceuticals
Next Earnings: 4 Aug 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 317.62    -9.65 (-2.95%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

28 Jun 2022


Loading...
Loading...
Loading...

General

CEO: Mr. David A. Ricks

IPO: 1978-01-13

Headquarters: US

Employees: 35,000

Homepage

Description

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Your Holdings
Dashboard
Portfolio
Options
Other Assets

Tools
Screener
Risk Manager
Other Assets
Watchlist
Alerts
Notes
Wall
Community
Forum
Blogs
Instagram
Facebook
Shared Portfolios
Shared Screeners

Collab
Tiger Brokers x StocksCafe
Saxo Trading x StocksCafe
Kenny REIT Screener

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
IG    FB    YouTube

About · FAQs · StocksCafe © 2022 · Privacy · Terms